Cardiovascular Effects of Marathon Running

Athletes Heart Clinical Trial

— FEIDIPIDIS  

Official title:

FEIDIPIDIS Study: Cardiovascular Effects of Marathon Running

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04738877
• Other study ID #: EC-3/2020
• Status: Completed
• Start date: February 2, 2021
• Est. completion date: August 30, 2021

Study information

• Verified date: November 2023
• Source: Aristotle University Of Thessaloniki
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The aim of this study is the investigation of acute cardiovascular responses of marathon runners after the completion of a marathon race (42.2 km), as well as of the determinants of these changes.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: August 30, 2021
• Est. primary completion date: August 30, 2021
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Marathon runner

Exclusion Criteria:

• Chronic disease, Drugs

Related Conditions & MeSH terms

• Athletes Heart

Intervention

Diagnostic Test:
• Body fat measurement
Body fat measurement using skinfolds
• Cardiopulmonary exercise testing
Electrocardiographic exercise testing with ergospirometer on a treadmill
• Echocardiography
Transthoracic echocardiography
• Blood test
Blood test for measurement of haemoglobin, serum electrolytes, iron, ferritin and vitamins

Locations

Country	Name	City	State
Greece	Aristotle University of Thessaloniki	Thessaloníki

Sponsors (1)

Lead Sponsor	Collaborator
Aristotle University Of Thessaloniki

Country where clinical trial is conducted

Greece, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Baseline left ventricular (LV) systolic function	Evaluation of LV ejection fraction	Evaluation of athletes within 3 weeks before the marathon running race.
Primary	Baseline LV diastolic function	Evaluation of LV filling pressures	Evaluation of athletes within 3 weeks before the marathon running race.
Primary	Baseline basal right ventricular (RV) function	Evaluation of tricuspid annular plane systolic excursion (TAPSE)	Evaluation of athletes within 3 weeks before the marathon running race.
Primary	Baseline global RV function	Evaluation of RV fractional are change (RVFAC)	Evaluation of athletes within 3 weeks before the marathon running race.
Primary	Post-exercise LV systolic function	Evaluation of LV ejection fraction	Evaluation of athletes immediately after the completion of the marathon running race.
Primary	Post-exercise LV diastolic function	Evaluation of LV filling pressures	Evaluation of athletes immediately after the completion of the marathon running race.
Primary	Post-exercise basal RV function	Evaluation of TAPSE	Evaluation of athletes immediately after the completion of the marathon running race.
Primary	Post-exercise global RV function	Evaluation of RVFAC	Evaluation of athletes immediately after the completion of the marathon running race.